Acknowledgement
This study was approved by the Institutional Review Board (IRB) of the Wonkwang University Hospital, and all participants provided written informed consent (IRB no. WKUH 2025-01-004).
References
- Maeda M, Saeki I, Sakaida I, et al. Complications after radiofrequency ablation for hepatocellular carcinoma: a multicenter study involving 9,411 Japanese patients. Liver Cancer 2020;9:50–62. https://doi.org/10.1159/000502744
- Fonseca AZ, Santin S, Gomes LG, et al. Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors. World J Hepatol 2014;6:107–113. https://doi.org/10.4254/wjh.v6.i3.107
- Howenstein MJ, Sato KT. Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol 2010;27:285-295. https://doi.org/10.1055/s-0030-1261787